Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies

被引：0
|
作者：
Christopher E. Collins
Josefina Cortes-Hernández
Mercedes A. Garcia
Johannes von Kempis
Andreas Schwarting
Zahi Touma
Milena Kurtinecz
Kerry Gairy
机构：
[1] MedStar Washington Hospital Center,University Medical Center
[2] Vall d’Hebron Hospital,Toronto Western Hospital
[3] HIGA San Martín,undefined
[4] Cantonal Hospital St. Gallen,undefined
[5] Johannes Gutenberg-University,undefined
[6] University of Toronto Lupus Clinic,undefined
[7] GSK,undefined
[8] GlaxoSmithKline,undefined
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Belimumab; Glucocorticosteroid sparing; Real-world effectiveness; Real-world experience; SLE; Systemic lupus erythematosus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：949 / 965
页数：16
相关论文
共 50 条
  • [21] Real-world data on the association between treatment beliefs, adherence and asthma outcomes: a multi-country study
    Chan, A. H. Y.
    Katzer, C. B.
    Pike, J.
    Small, M.
    Horne, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 307 - 307
  • [22] REAL-WORLD EVALUATION OF HEALTH DISPARITIES IN TREATMENT PATTERNS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
    Nayak, P.
    Cyhaniuk, A.
    Prasad, S.
    Pfeffer, D.
    Shokoohi, M.
    Kish, J.
    VALUE IN HEALTH, 2023, 26 (06) : S207 - S207
  • [23] Systemic Lupus Erythematosus Symptom Clusters and Their Association With Patient-Reported Outcomes and Treatment: Analysis of Real-World Data
    Touma, Zahi
    Hoskin, Ben
    Atkinson, Christian
    Bell, David
    Massey, Olivia
    Lofland, Jennifer H.
    Berry, Pamela
    Karyekar, Chetan S.
    Costenbader, Karen H.
    ARTHRITIS CARE & RESEARCH, 2022, 74 (07) : 1079 - 1088
  • [24] Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
    Wallace, D. J.
    Navarra, S.
    Petri, M. A.
    Gallacher, A.
    Thomas, M.
    Furie, R.
    Levy, R. A.
    van Vollenhoven, R. F.
    Cooper, S.
    Zhong, Z. J.
    Freimuth, W.
    Cervera, R.
    LUPUS, 2013, 22 (02) : 144 - 154
  • [25] Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi-omics analysis
    Fujio, Keishi
    Ushijima, Toshiyuki
    Abe, Tatsuki
    Okamura, Tomohisa
    Bae, Sang-Cheol
    Tsuchida, Yumi
    RHEUMATOLOGY & AUTOIMMUNITY, 2025,
  • [26] Real-World Prevalence, Incidence and Management of Systemic Lupus Erythematosus in Germany: A Retrospective Claims Data Analysis
    Alexander, Tobias
    Sewerin, Philipp
    Strangfeld, Anja
    Schulte, Marcus
    Borchert, Julia
    Garcia, Tarcyane Barata
    Schrom, Eva
    RHEUMATOLOGY AND THERAPY, 2025, 12 (02) : 237 - 254
  • [27] Real-world efficacy of belimumab in achieving remission or low-disease activity in systemic lupus erythematosus: A retrospective study
    Hasegawa, Yasuhiro
    Arinuma, Yoshiyuki
    Asakura, Hirotomo
    Shindo, Risa
    Ino, Kazuma
    Kanayama, Yoshiro
    Tanaka, Tomoki
    Matsueda, Yu
    Wada, Tatsuhiko
    Oku, Kenji
    Yamaoka, Kunihiro
    MODERN RHEUMATOLOGY, 2023, : 732 - 740
  • [28] DIAGNOSTIC CLUSTER PROFILING OF PATIENTS IN A REAL-WORLD DATA SET WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Touma, Z.
    Hoskin, B.
    Atkinson, C.
    Bell, D.
    Massey, O.
    Lofland, J. H.
    Berry, P.
    Karyekar, C.
    Costenbader, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 346 - 346
  • [29] BELIMUMAB FOR THE TREATMENT OF ADULTS LIVING WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: A COST-EFFECTIVENESS ANALYSIS IN CANADA
    Mursleen, S.
    Gahn, J. C.
    Klein, R. W.
    Asukai, Y.
    VALUE IN HEALTH, 2018, 21 : S254 - S255
  • [30] Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage
    Eviatar, Tali
    Yahalom, Roni
    Livnat, Idit
    Elboim, Moran
    Elkayam, Ori
    Chodick, Gabriel
    Rosenberg, Vered
    Paran, Daphna
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):
12345